NEW SEARCH | HOME | HELP

{link: 'http://hdl.loc.gov/loc.uscongress/legislation.111hr1549',title: 'Thomas - Bill Summary and Status - H.R.1549' }

H.R.1549
Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.
Sponsor: Rep Slaughter, Louise McIntosh [NY-28] (introduced 3/17/2009)      Cosponsors (104)
Related Bills: S.619
Latest Major Action: 7/13/2009 House committee/subcommittee actions. Status: Committee Hearings Held.
Jump to: Summary, Major Actions, All Actions, Titles, Cosponsors, Committees, Related Bill Details, Amendments

SUMMARY AS OF:
3/17/2009--Introduced.

Preservation of Antibiotics for Medical Treatment Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.

Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met. Directs specified congressional committees to hold hearings on the implementation of such a withdrawal of approval.


MAJOR ACTIONS:

***NONE***


ALL ACTIONS:
3/17/2009:
Sponsor introductory remarks on measure. (CR E689)
3/17/2009:
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
3/17/2009:
Referred to House Energy and Commerce
3/17/2009:
Referred to House Rules
7/13/2009:
Committee Hearings Held.

TITLE(S):  (italics indicate a title for a portion of a bill)
COSPONSORS(104), ALPHABETICAL [followed by Cosponsors withdrawn]:     (Sort: by date)


COMMITTEE(S):
RELATED BILL DETAILS:  (additional related bills may be indentified in Status)
AMENDMENT(S):

***NONE***